James Polli

University of Maryland Recognizes Polli as MPower Professor

December 20, 2023

James Polli, PhD, leads multiple intercampus research centers in regulatory science and drug quality.

Pharmaceutical Sciences Professor Selected for International Award

September 9, 2022

James Polli leads two centers and an academic program at UMSOP.

Minding the ABC’s of Complex Generic Drugs: Access, Bioequivalence, and Complexity

January 1, 2022

New center strives to help develop generics and patients who need them

Director of MS in Regulatory Science Program Receives International Education Award

December 17, 2021

TOPRA Awards for Regulatory Excellence recognize high achievements in regulatory affairs community

Faculty Members’ Research Impacts FDA Guidance

November 30, 2021

Adjustments on detection method, type of trial should make it easier to gain approval of generic injectable iron drugs.

Ninth Annual M-CERSI Regulatory Science Competition Goes Virtual

January 19, 2021

Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.

Grant Increases Access, Safety of Generic Drugs

September 29, 2020

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

SOP Hosts Eighth Annual “America’s Got Regulatory Science Talent” Competition

March 23, 2020

Team of second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.

M-CERSI Conference Spotlights Regulatory Applications for Dissolution Testing

June 13, 2019

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.

Student Competition Spotlights Innovation in Regulatory Science

February 21, 2019

Third-year student pharmacists take the gold for their proposal to establish regulatory standards that protect patient privacy for individuals using wearable and implantable medical technologies.

M-CERSI Cooperative Agreement Grant Renewed by Food and Drug Administration

October 3, 2018

Latest renewal allows for up to $5 million per year over five years, and will help M-CERSI further advance its mission to promote the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.

Ensuring Prescription Drug Quality for All Patients

May 24, 2018

Dr. James Polli’s extraordinary accomplishments in the field of regulatory science make him a UMB Champion of Excellence.